# Alvine Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alvine-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Carlos, US
- Website: www.alvinepharma.com
- Total disclosed funding: $42M
- Latest round: Series B (Sep 4, 2009)
- Investors on record: 7

## About

Founded in 2005 and based in California, US, Alvine Pharmaceuticals, Inc. is a biopharmaceutical company that operates as a producer of medical drugs for inflammatory and celiac diseases.

## Funding rounds

- Series B, Sep 4, 2009, $8.5M — Flagship Pioneering, InterWest Partners, Prospect Venture Partners, Sofinnova Investments, Panorama Capital, Black River Asset Management
- Series A, May 2, 2008, $26M — Flagship Pioneering, InterWest Partners, Prospect Venture Partners, Sofinnova Investments, Cargill Ventures
- Series A, Sep 12, 2006, $7M — Flagship Pioneering, InterWest Partners, Prospect Venture Partners, Sofinnova Investments, Cargill Ventures

## Investors

- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A, Series B
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series A, Series B
- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series A, Series B
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B
- Cargill Ventures (https://capitalatlas.ai/funds/cargill-ventures) — Series A
- Panorama Capital — Series B
- Black River Asset Management (https://capitalatlas.ai/funds/black-river-asset-management) — Series B